Skip to main content
SpringerLink
Log in

Koexistenz der Prothrombinvariante 20210 GA bei Patienten mit der Faktor-V: R506Q-Mutation und venöser Thrombophilie

  • Conference paper
Book cover 28. Hämophilie-Symposion Hamburg 1997

  • 35 Accesses

Zusammenfassung

Die durch die 1691 GA-Mutation im Faktor-V-Gen bedingte APC-Resistenz (FV:R5O6Q) (Dahlbäck et al. 1993; Bertina et al. 1994; Greengard et al. 1994) gilt derzeit als häufigster hereditärer Risikofaktor für venöse Thromboembolien (VTE) mit einer durchschnittlichen Prävalenz von 22% (range 20-52%) bei Patienten mit primarer VTE (de Stefano et al. 1996; Griffin et al. 1993; Koster et al. 1993; Svensson et al. 1994; Nowak-Göttl et al. 1996; Ehrenforth et al. 1998a).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 44.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 59.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Alhenc-Gelas M, Le Cam-Duchez V, Emmerich J, Frebourg T, Fiessinger JN, Borg JY, Aiach M (1997) The A20210 allele of the prothrombin gene is not frequently associated with the factor V Arg 506 to Gin mutation in thrombophilie patients. Blood 90: 1711

    PubMed  CAS  Google Scholar 

  2. Bertina RM, Koeleman, BPC, Koster T, Rosendaal FR, Dirven RJ, de Ronde H, van der Velden PA, Reitsma PH (1994) Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 369: 64–67

    CAS  Google Scholar 

  3. Boven van HA, Reitsma PH, Rosendaal FR, Bayston TA, Chowdhury V, Bauer KA, Scharrer I, Conard J, Lane DA (1996) Factor V Leiden (FV: R506Q) in families with inherited antithrombin deficiency. Thromb Haemost 75: 417–421

    PubMed  Google Scholar 

  4. Brown K, Luddington R, Williamson D, Baker P, Baglin T (1997) Risk of venous thrombo-embolism associated with a G to A transition at position 20210 in the 3’-untranslated region of the prothrombin gene. Br J Haematol 98: 907–909

    Article  PubMed  CAS  Google Scholar 

  5. Cumming AM, Keeney S, Salden A, Bhavnani M, Shwe KH, Hay CRM (1997) The prothrombin gene C20210A variant: prevalence in a U.K. anticoagulant clinic population. Br J Haematol 98: 353–355

    Article  PubMed  CAS  Google Scholar 

  6. Dahlbäck B, Carlsson M, Svensson PJ (1993) Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C. Proc Natl Acad Sci USA 90: 1004–1008

    Article  PubMed  Google Scholar 

  7. Ehrenforth S, Zwinge B, Scharrer I (1998) High pr evalence of factor V R506Q mutation in german thrombophilie and normal population. Thromb Haemostas 79 (3): 684–5

    CAS  Google Scholar 

  8. Ehrenforth S, Nowak-Göttl U, Ludwig G, Klinke S, Krause M, Scharrer I (1998) The prothrombin 20210 A allele is frequently coinherited in young carriers of the factor V Arg 506 to Gin mutation with venous thrombophilia. Blood 91 (6): 2209–10

    PubMed  CAS  Google Scholar 

  9. Gandrille SG, Greengard JS, Alhenc-Gelas M, Juhan-Vague I, Abgrall JF, Jude B, Griffin JH, Aiach M, The French Network on behalf of INSERM (1995a) Incidence of activated protein C resistance caused by the ARG 506 GLN mutation in factor V in 113 unrelated symptomatic protein C-deficient patients. Blood 86: 219–224

    CAS  Google Scholar 

  10. Gandrille S, Borgel D, Aiach M, The French Network INSERM on molecular abnormalities responsible for protein C and protein S deficiencies (1995b) Incidence of activated protein C resistance due to ARG 506 GLN mutation in factor V in 116 unrelated propositus from families with protein S deficiency. Thromb Haemost 73: 1372 (abst.)

    Google Scholar 

  11. Greengard JS, Sun X, Xu X, Fernandez JA, Griffin JH, Evatt B (1994) Activated protein C resistance caused by Arg506Gln mutation in factor Va. Lancet 343: 1361–1362

    Article  PubMed  CAS  Google Scholar 

  12. Griffin JH, Evatt B, Widermann C, Fernandez JA (1993) Anticoagulant protein C pathway defective in majority of thrombophilie patients. Blood 82: 19891–1993

    Google Scholar 

  13. Hillarp A, Zöller B, Svensson PJ, Dahlback B (1997) The 20210 A allele of the prothrombin gene is a common risk factor among swedish outpatients with verified deep venous thrombosis. Thromb Haemost 78: 990–992

    PubMed  CAS  Google Scholar 

  14. Koelemann BPC, Reitsma PH, Allaart CF, Bertina RM (1994) Activated protein C resistance as an additional risk factor for thrombosis in protein C-deficient families. Blood 84: 1031–1035

    Google Scholar 

  15. Koelemann BPC, van Rumpt D,Hamulyak K, Reitsma PH, Bertina RM (1995) Factor V Leiden: an additional risk factor for thrombosis in protein S deficient families? Thromb Haemost 74: 580–583

    Google Scholar 

  16. Koster T, Rosendaal FR, Ronde de H, Briet E, Vandenbroucke JP, Bertina RM (1993) Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden Thrombophilia Study. Lancet 342: 1503–1506

    Google Scholar 

  17. Nowak-Gottl U, Koch HG, Aschka I, Kohlhase B,Vielhaber H, Kurlemann G, Oleszuk-Raschke K, Kehl HG, Jürgens H, Schneppenheim R (1996) Resistance to activated protein C ( APCR) in children with venous or arterial thromboembolism. Br J Haematol 92: 992–996

    Google Scholar 

  18. Poort SR, Rosendaal FR, Reitsma PH, Bertina RM (1996) A common genetic variation in the 3’-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood 88: 3698 - 3703

    PubMed  CAS  Google Scholar 

  19. Rees DC, Cox M, Clegg JB (1995) World distribution of factor V Leiden. Lancet 346: 1133–1134

    Article  PubMed  CAS  Google Scholar 

  20. Rosendaal FR, Siscovic DS, Schwartz SM, Psaty BM, Raghunathan TE, Vos HL (1997) A common prothrombin variant (20210 G to A) increases the risk of myocardial infarction in young women. Blood 90 (5): 1747–1750

    PubMed  CAS  Google Scholar 

  21. Seligsohn U, Zivelin A (1997) Thrombophilia as a multigenic disorder. Thromb Haemost 78 (1): 297–301

    PubMed  CAS  Google Scholar 

  22. Stefano de V, Finazzi G, Mannucci PM (1996) Inherited thrombophilia. Pathogenesis, clinical syndromes and management. Blood 87: 3531–3544

    Google Scholar 

  23. Svensson PJ, Dahlback B (1994) Resistance to activated protein C as a basis for venous thrombosis. N Engl J Med 330: 517–522

    Article  PubMed  CAS  Google Scholar 

  24. Zöller B, Berntsdotter A, Frutos de PC, Dahlbäck B (1995) Resistance to activated protein C as an additional genetic risk factor in hereditary deficiency of protein S. Blood 85: 3518–3523

    Google Scholar 

Download references

Authors
  1. S. Ehrenforth
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. E. Aygören-Pürsün
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. S. Klinke
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. M. Krause
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. G. Ludwig
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. A. Wenke
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. B. Zwinge
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. I. Scharrer
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Zentr. d. Inn. Med., Med. Klinik I Universitätsklinikum, Theodor-Stern-Kai 7, D-60590, Frankfurt am Main, Germany

    Inge Scharrer

  2. Hämostaseologische Abteilung, Med. Univ.-Klinik Innenstadt, Ziemssenstraße 1a, D-80336, München, Germany

    Wolfgang Schramm

  3. Hämophilieambulanz, Zentrum, Innere Medizin, Klinikum der Johann-Wolfgang, Goethe-Universität, Frankfurt am Main, Germany

    Inge Scharrer

  4. Abt. Hämostaseologie, Medizinische Klinik Innenstadt, Ludwig-Maximilians-Universität, München, Germany

    Wolfgang Schramm

Rights and permissions

Reprints and permissions

Copyright information

© 1999 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Ehrenforth, S. et al. (1999). Koexistenz der Prothrombinvariante 20210 GA bei Patienten mit der Faktor-V: R506Q-Mutation und venöser Thrombophilie. In: Scharrer, I., Schramm, W. (eds) 28. Hämophilie-Symposion Hamburg 1997. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-59915-6_9

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-59915-6_9

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-64581-8

  • Online ISBN: 978-3-642-59915-6

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation